It is not licensed for human use in the UK and holds no MHRA (Medicines and Healthcare products Regulatory Agency) marketing authorisation as of 2026 [7]
Every legitimate compounded GLP-1 should disclose active peptide and concentration (mg/mL), solvent (usually bacteriostatic water), and any additives (B12, niacinamide, lidocaine)
Some individuals may assume all lower-cost GLP-1 products are identical to brand-name therapies, even when biosimilar differences exist
Mild Swelling Temporary swelling may occur immediately after an injection and often resolves without treatment
Essential Extras: In July 2025, GenoGenix initiated a large recall of semaglutide, tirzepatide, retatrutide, GLP-1 vitamin combination products, and 54 additional compounded injectables, including vitamins and vitamin blends like Amino Blend, Vitamin D-3, Lipo MIC +B12 Methylcobalamin, and more, due to product sterility problems
Routing intake information to clinicians and coordinating approved prescriptions with pharmacies